EOS IMAGING : 2013 Financial Calendar

Regulatory News:

EOS imaging (NYSE Euronext, FR0011191766 - EOSI), the pioneer in 2D/3D orthopedic medical imaging, today announces its financial communication schedule for 2013. The press releases are published after market close. This schedule is indicative and subject to change.

-- 2012 Full year results				Thursday 18 April, 2013
-- 2013 First-quarter revenues				Tuesday 23 April, 2013
-- 2013 First-half revenues				Wednesday 17 July, 2013
-- 2013 First-half results				Thursday 29 August, 2013
-- 2013 Third-quarter revenues				Tuesday 15 October, 2013

For more information on EOS and its technology, visit www.eos?imaging.com.

About EOS imaging:

The EOS imaging group designs, develops and markets EOS®, a revolutionary and patented medical imaging system, based on technology that enabled George Charpak to win the Nobel Prize for Physics. The Group has obtained authorization to market the system in 30 countries, including the United States (FDA), Canada, Australia and the European Union (EU). Thanks to an installed base of 53 sites and more than 250,000 imaging sessions, EOS® benefits from worldwide recognition and established credibility within the medical community. The Group currently employs 63 people, including an R&D team of 23 engineers, and recorded consolidated revenue of ?9.41 million in 2012. The Group's head office is based in Paris, with a subsidiary in the United States in Cambridge (Massachusetts), as well as in Montreal (Canada) and Germany. For further information, please go to: www.eos?imaging.com.

EOS imaging is listed on Compartment C of the NYSE Euronext Paris

ISIN: FR0011191766 - Ticker: EOSI

Anne Renevot
CFO
Tel.: [phone]
[e-mail]
or
The Ruth Group (US)
Press Relations - Lisa Cook
Ph: 646-536-7012
[e-mail]
or
NewCap.
Financial communication and investor relations
Sophie Boulila / Pierre Laurent
Tel.: [phone]
[e-mail]
or
ALIZE RP (Europe)
Press Relations
Caroline Carmagnol
Tel: [phone]
[e-mail]